metastatic clear cell Renal Carcinoma Cell research hub

Multicentric trial evaluating the correlation between early PSMA-PET change and response to systemic treatment for first-line metastatic clear cell Renal Carcinoma Cell.

This study looks at how a scan called PSMA-PET changes in people with advanced kidney cancer when they start new treatments. We want to see if these early changes on the scan can predict how well the treatment is working after six months.